论文部分内容阅读
甲状腺癌是最常见的甲状腺恶性肿瘤,约占全身恶性肿瘤的1%。手术治疗是除了未分化癌以外各型甲状腺癌的基本治疗方法,并辅助应用核素、甲状腺激素及放射线照射等治疗。关于甲状腺癌术后是否需要服药以及如何服药是许多患者关心的问题。甲状腺癌术后是否需要服药?针对这个问题的回答是肯定的。为了降低复发风险,分化型甲状腺癌患者应该接受长期的内分泌治疗,即促甲状腺激素(TSH)抑制治疗。不仅是双侧甲状腺全切除术后的患者,同时也推荐用于部分切除术后的患者,亦是转移性疾病的治疗方式。TSH抑制治疗是降低分化型甲状腺癌复发率的重要辅助措施。其理论依据在于研究发现分化型甲状腺癌细胞膜表面表达TSH受体,可以对TSH的刺激做出反应,促
Thyroid cancer is the most common thyroid malignancy, accounting for about 1% of systemic malignancies. Surgical treatment is the basic treatment for all types of thyroid cancer in addition to undifferentiated carcinoma, and assist in the treatment of radionuclides, thyroid hormones and radiation exposure. It is a matter of concern to many patients about the need for medication and how to take medicine after surgery for thyroid cancer. Do thyroid cancer require medication after surgery? The answer to this question is yes. In order to reduce the risk of relapse, patients with differentiated thyroid cancer should receive long-term endocrine therapy, which is thyroid-stimulating hormone (TSH) suppression therapy. Not only in patients with bilateral total thyroidectomy, but also recommended for patients after partial resection, but also the treatment of metastatic disease. TSH suppression therapy is an important adjunct to reduce the recurrence rate of differentiated thyroid cancer. The rationale is that the study found that differentiated thyroid cancer cell membrane surface expression of TSH receptors, can stimulate the response to TSH, and promote